142 related articles for article (PubMed ID: 11113544)
21. Inhibitory action of dopamine involves a subthreshold Cs(+)-sensitive conductance in neostriatal neurons.
Pacheco-Cano MT; Bargas J; Hernández-López S; Tapia D; Galarraga E
Exp Brain Res; 1996 Jul; 110(2):205-11. PubMed ID: 8836685
[TBL] [Abstract][Full Text] [Related]
22. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
LaHoste GJ; Marshall JF
Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
[TBL] [Abstract][Full Text] [Related]
23. Dopamine inhibits somatolactin gene expression in tilapia pituitary cells through the dopamine D2 receptors.
Jiang Q; Lian A; He Q
Comp Biochem Physiol A Mol Integr Physiol; 2016 Jul; 197():35-42. PubMed ID: 26970582
[TBL] [Abstract][Full Text] [Related]
24. Dopamine D1 and D2 receptor Co-activation generates a novel phospholipase C-mediated calcium signal.
Lee SP; So CH; Rashid AJ; Varghese G; Cheng R; Lança AJ; O'Dowd BF; George SR
J Biol Chem; 2004 Aug; 279(34):35671-8. PubMed ID: 15159403
[TBL] [Abstract][Full Text] [Related]
25. Selective inhibition of adenylyl cyclase type V by the dopamine D3 receptor.
Robinson SW; Caron MG
Mol Pharmacol; 1997 Sep; 52(3):508-14. PubMed ID: 9281614
[TBL] [Abstract][Full Text] [Related]
26. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats.
Moro H; Sato H; Ida I; Oshima A; Sakurai N; Shihara N; Horikawa Y; Mikuni M
Pharmacol Biochem Behav; 2007 May; 87(1):56-64. PubMed ID: 17499349
[TBL] [Abstract][Full Text] [Related]
27. Desensitization of the dopamine D1 and D2 receptor hetero-oligomer mediated calcium signal by agonist occupancy of either receptor.
So CH; Verma V; O'Dowd BF; George SR
Mol Pharmacol; 2007 Aug; 72(2):450-62. PubMed ID: 17519357
[TBL] [Abstract][Full Text] [Related]
28. Reduced D2-mediated signaling activity and trans-synaptic upregulation of D1 and D2 dopamine receptors in mice overexpressing the dopamine transporter.
Ghisi V; Ramsey AJ; Masri B; Gainetdinov RR; Caron MG; Salahpour A
Cell Signal; 2009 Jan; 21(1):87-94. PubMed ID: 18929645
[TBL] [Abstract][Full Text] [Related]
29. Striatal gene expression of RGS2 and RGS4 is specifically mediated by dopamine D1 and D2 receptors: clues for RGS2 and RGS4 functions.
Taymans JM; Leysen JE; Langlois X
J Neurochem; 2003 Mar; 84(5):1118-27. PubMed ID: 12603835
[TBL] [Abstract][Full Text] [Related]
30. Striatal dopamine receptor plasticity in neurotensin deficient mice.
Chastain LG; Qu H; Bourke CH; Iuvone PM; Dobner PR; Nemeroff CB; Kinkead B
Behav Brain Res; 2015 Mar; 280():160-71. PubMed ID: 25449842
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the ability of dopamine receptor agonists to inhibit forskolin-stimulated adenosine 3'5'-cyclic monophosphate (cAMP) accumulation via D2L (long isoform) and D3 receptors expressed in Chinese hamster ovary (CHO) cells.
Hall DA; Strange PG
Biochem Pharmacol; 1999 Jul; 58(2):285-9. PubMed ID: 10423170
[TBL] [Abstract][Full Text] [Related]
32. Dopamine acting at D1-like, D2-like and α1-adrenergic receptors differentially modulates theta and gamma oscillatory activity in primary motor cortex.
Özkan M; Johnson NW; Sehirli US; Woodhall GL; Stanford IM
PLoS One; 2017; 12(7):e0181633. PubMed ID: 28732063
[TBL] [Abstract][Full Text] [Related]
33. The human D2 dopamine receptor synergizes with the A2A adenosine receptor to stimulate adenylyl cyclase in PC12 cells.
Kudlacek O; Just H; Korkhov VM; Vartian N; Klinger M; Pankevych H; Yang Q; Nanoff C; Freissmuth M; Boehm S
Neuropsychopharmacology; 2003 Jul; 28(7):1317-27. PubMed ID: 12784121
[TBL] [Abstract][Full Text] [Related]
34. Dopaminergic modulation of nitric oxide synthase activity in subregions of the rat nucleus accumbens.
Hoque KE; West AR
Synapse; 2012 Mar; 66(3):220-31. PubMed ID: 22034069
[TBL] [Abstract][Full Text] [Related]
35. D2 and D1 dopaminergic activity of 7-OH-DPAT.
Sethy VH; Ellerbrock BR; Fici GJ; Wu H
Brain Res; 1996 Sep; 733(1):41-5. PubMed ID: 8891246
[TBL] [Abstract][Full Text] [Related]
36. Differential ability of D1 and D2 dopamine receptor agonists to induce and modulate expression and reinstatement of cocaine place preference in rats.
Graham DL; Hoppenot R; Hendryx A; Self DW
Psychopharmacology (Berl); 2007 Apr; 191(3):719-30. PubMed ID: 16835769
[TBL] [Abstract][Full Text] [Related]
37. D1 and D2 receptor-mediated dopaminergic modulation of visual responses in cat dorsal lateral geniculate nucleus.
Zhao Y; Kerscher N; Eysel U; Funke K
J Physiol; 2002 Feb; 539(Pt 1):223-38. PubMed ID: 11850515
[TBL] [Abstract][Full Text] [Related]
38. CB1 receptor knockout mice display reduced ethanol-induced conditioned place preference and increased striatal dopamine D2 receptors.
Houchi H; Babovic D; Pierrefiche O; Ledent C; Daoust M; Naassila M
Neuropsychopharmacology; 2005 Feb; 30(2):339-49. PubMed ID: 15383833
[TBL] [Abstract][Full Text] [Related]
39. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
Pollack AE; Yates TM
Neuroscience; 1999; 94(2):505-14. PubMed ID: 10579212
[TBL] [Abstract][Full Text] [Related]
40. Dopamine D1, dopamine D2, and prolactin receptor messenger ribonucleic acid expression by the polymerase chain reaction in human meningiomas.
Carroll RS; Schrell UM; Zhang J; Dashner K; Nomikos P; Fahlbusch R; Black PM
Neurosurgery; 1996 Feb; 38(2):367-75. PubMed ID: 8869066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]